Endocrinology Research and Practice
Original Articles

Factors Associated with Microalbuminuria in Patients with Type 2 Diabetes: A Cross-sectional Study from Eastern India

1.

Department of Endocrinology, Nutrition and Metabolic Diseases, School of Tropical Medicine, Kolkata, India

2.

Department of Infectious Diseases and Advanced Microbiology, School of Tropical Medicine, Kolkata, India

Endocrinol Res Pract 2024; 28: 224-228
DOI: 10.5152/erp.2024.24451
Read: 396 Downloads: 190 Published: 19 August 2024

Objective: The current cross-sectional study determines the prevalence and associated factors of microalbuminuria in a focused population in Eastern India.

Methods: The study was conducted in Kolkata from June to December 2022 among type 2 diabetes mellitus (T2DM) patients. Patients with T2DM aged more than 18 were included in the study, and those with overt albuminuria (>300 mg/day), congestive cardiac failure, urinary tract infection, pregnancy, human immunodeficiency virus, hepatitis B, or hepatitis C infection were excluded.

Results: Among 297 T2DM patients, 130 (43.8%) had high albumin creatinine ratio (> 30 mg/g). Diabetic patients with elevated blood pressure (BP > 130/80 mm Hg) were 1.68 times (95% CI, 1.12- 2.53) at risk of developing microalbuminuria. Similarly, patients with a diabetes duration of 5 years or more were 1.48 (95% CI 1.09-2.02) times more likely to develop microalbuminuria. Logistic regression also concluded that elevated blood pressure (BP > 130/80 mm Hg, P=.027) and duration of diabetes (>5 years, P=.016) were predictive of microalbuminuria.

Conclusion: The current study observes a high prevalence of microalbuminuria among diabetes patients. This indicates the need for the implementation of preventive strategies for diabetic nephropathy, especially among patients with long-standing diabetes and elevated blood pressure.

Cite this article as: Naskar A, Mondal A. Factors associated with microalbuminuria in patients with type 2 diabetes: A crosssectional study from Eastern India. Endocrinol Res Pract. 2024;28(4):224-228.

Files
EISSN 2822-6135